Chapple CR - Search Results

1

Another Therapeutic Role for Intravesical Botulinum Toxin: Patients with Long-stay Catheters and Refractory Bladder Pain and Catheter Bypass Leakage.

Young MJ, Osman NI, Phillips L, Mangera A, Reid SV, Inman RD, Chapple CR. Young MJ, et al. Among authors: chapple cr. Eur Urol Focus. 2020 Mar 15;6(2):339-343. doi: 10.1016/j.euf.2018.10.011. Epub 2018 Nov 2. Eur Urol Focus. 2020. PMID: 30392867

2

An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence.

Chapple CR, Haab F, Cervigni M, Dannecker C, Fianu-Jonasson A, Sultan AH. Chapple CR, et al. Eur Urol. 2005 Sep;48(3):488-94. doi: 10.1016/j.eururo.2005.05.007. Eur Urol. 2005. PMID: 15967568 Clinical Trial.

3

Stress incontinence injection therapy: what is best for our patients?

Chapple CR, Wein AJ, Brubaker L, Dmochowski R, Pons ME, Haab F, Hill S. Chapple CR, et al. Eur Urol. 2005 Oct;48(4):552-65. doi: 10.1016/j.eururo.2005.06.012. Eur Urol. 2005. PMID: 16118034 Review.

4

Effect of an ATP-sensitive potassium channel opener in subjects with overactive bladder: a randomized, double-blind, placebo-controlled study (ZD0947IL/0004).

Chapple CR, Patroneva A, Raines SR. Chapple CR, et al. Eur Urol. 2006 May;49(5):879-86. doi: 10.1016/j.eururo.2006.01.037. Epub 2006 Feb 24. Eur Urol. 2006. PMID: 16517051 Clinical Trial.

5

A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.

Chapple CR, Roehrborn CG. Chapple CR, et al. Eur Urol. 2006 Apr;49(4):651-8. doi: 10.1016/j.eururo.2006.02.018. Epub 2006 Feb 17. Eur Urol. 2006. PMID: 16530611 Review.

6

Botulinum toxin in urinary incontinence.

Patterson JM, Chapple CR. Patterson JM, et al. Among authors: chapple cr. Curr Opin Urol. 2006 Jul;16(4):255-60. doi: 10.1097/01.mou.0000232046.87803.57. Curr Opin Urol. 2006. PMID: 16770124 Review.

7

Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: A critical analysis of results.

Patel AK, Patterson JM, Chapple CR. Patel AK, et al. Among authors: chapple cr. Eur Urol. 2006 Oct;50(4):684-709; discussion 709-10. doi: 10.1016/j.eururo.2006.07.022. Epub 2006 Aug 4. Eur Urol. 2006. PMID: 16934391 Review.

8

Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.

Chapple CR, Fianu-Jonsson A, Indig M, Khullar V, Rosa J, Scarpa RM, Mistry A, Wright DM, Bolodeoku J; STAR study group. Chapple CR, et al. Eur Urol. 2007 Oct;52(4):1195-203. doi: 10.1016/j.eururo.2007.05.027. Epub 2007 Jun 6. Eur Urol. 2007. PMID: 17574730 Clinical Trial.

9

Management of the failure of a permanently implanted urethral stent-a therapeutic challenge.

Chapple CR, Bhargava S. Chapple CR, et al. Eur Urol. 2008 Sep;54(3):665-70. doi: 10.1016/j.eururo.2007.11.024. Epub 2007 Nov 20. Eur Urol. 2008. PMID: 18054424

10

Tissue-engineered buccal mucosa urethroplasty-clinical outcomes.

Bhargava S, Patterson JM, Inman RD, MacNeil S, Chapple CR. Bhargava S, et al. Among authors: chapple cr. Eur Urol. 2008 Jun;53(6):1263-9. doi: 10.1016/j.eururo.2008.01.061. Epub 2008 Feb 4. Eur Urol. 2008. PMID: 18262717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page